Tuesday, July 5, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Whitepapers

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

by Medical Finance
in Whitepapers
IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”
9
SHARES
104
VIEWS
Share on FacebookShare on Twitter

IVIM Technology, Inc. recently released IVM-MS2 – the most compact all-in-one intravital two-photon microscope on the market.

The first start-up to commercialize all-in-one integrated intravital microscopy equipment, instrumentation from IVIM Technology, Inc. employs innovative intravital microscopy (IVM) technology that was initially developed by KAIST.

The IVM-MS2 instrument has been optimized for in vivo imaging experiments. It features a novel, compact, extremely efficient, highly stable and maintenance-free fs-pulse laser module and represents an excellent option for customers with limited budgets and resources.

The two-photon intravital microscope is a popular choice in advanced bioresearch institutes around the world, with the IVM-MS2 already set to be installed at the Max Planck Institute in Germany and the Harvard Medical School in the United States.

The IVM-MS2 integrates the complete range of functions required in the imaging of numerous processes in living animals with high cellular and molecular resolutions, allowing users at all experience levels to achieve optimum results with ease.

It also features a range of imaging algorithms that can automatically compensate for movement, for example, lung movements caused by respiration and heartbeats.

This is made possible by the IVM-MS2’s unique ultra-high speed in vivo imaging capabilities (maximum of 100 fps at 512 x 512 pixels) and its innovative live animal maintenance system designed to preserve tissues’ physiological environment throughout the image acquisition process.

IVM-MS2 boasts an industry-leading, ultra-small, ultra-fast 920 nm fs-pulse laser module. The 920 nm wavelength is the most employed wavelength in two-photon microscopy, facilitating the efficient, simultaneous two photon-excitation of a range of fluorescents.

The space-saving, high performance, affordable IVM-MS2 enables researchers to reliably investigate a range of biological processes in living animals with no fluorescence limitations.

IVIM Technology, Inc. offers a number of other product lines, including:

  • The IVM-C all-in-one confocal microscope
  • The IVM-M multi-photon microscope
  • The IVM-CM confocal/multi-photon microscope

IVIM Technology, Inc. also provides a portfolio of customized experimental services. These services utilize customers’ drug candidates or molecules and are provided by experienced researchers from the IVIM Corporate Research Institute, all of whom possess PhDs from KAIST.

The biopharmaceutical industry has recently shifted its focus from the development of synthetic drugs to the development of new biopharmaceutical techniques, such as immunotherapy, cell therapy, antibody therapy and gene therapy.

The human body operates through innumerable complex interactions, but studies employed in preclinical drug development stages have been traditionally conducted without interaction, such as in vitro and ex vivo experiments.

IVIM Technology‘s ultra-fast three-dimensional laser scanning intravital microscopy facilitates the direct observation of cell movement inside living tissues. It also enables investigation into individual cells moving inside the body’s organs – even those that cannot be seen with CT or MRI.

It is also possible to simultaneously image cells and molecules (for example, proteins) and their surrounding microenvironments with higher precision and resolutions than have previously been allowed by existing technologies.

These additional capabilities are vital in the acquisition of detailed information on the process of diseases occurring in the body at a cellular level.

Intravital microscopy systems from IVIM Technology can be utilized in:

  • In vivo 4D cell imaging, tracking and monitoring
  • In vivo imaging of drug efficacy
  • In vivo imaging of drug delivery
  • High resolution intravital imaging of almost all organs and tissues

IVIM Technology’s methods and instruments are ideally suited for the accurate identification of drug mechanisms, particularly those occurring in new drug studies such as bispecific antibodies, microbiomes and exosomes.

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

Image Credit: IVIM Technology

About IVIM Technology0 (2)

IVIM Technology was founded based on the innovative technology of IntraVital Microscopy (IVM) developed by the Korea Advanced Institute of Technology (KAIST).

IntraVital Microscopy is a technique that enables you to directly observe the movement of live cells that make up living tissue in vivo.

With this technique, it is possible to distinguish an individual cell among a large number of cells in various organs, which is not possible with conventional biomedical imaging technologies such as MRI or CT, and to track the movement of each cell in three dimensions in real-time.

It is also possible to simultaneously image living cells in living organs, surrounding microenvironments, and molecules such as proteins which is impossible with conventional tissue analysis technology.

Furthermore, this enables us to analyze the in vivo efficacy of new biopharmaceuticals such as immunological, cell, gene, and antibody therapeutic agents acting in real living organisms at the cellular level which is the basic structural and functional unit of life.

The world’s first All-in-One microscopy (IVM) platform developed by IVIM Technology explores the interactions among numerous cells inside the living organisms and will be the next generation high-tech imaging equipment to elucidate the complex processes of human diseases.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

The DynaPro NanoStar utilizes an intuitive on-board app, DYNAMICS Touch, for guided measurements and walk-up operation. Advanced analyses such as onset temperature are carried out using the full-fea-tures DYNAMICS software, which runs on a standard Windows PC.

Thermostability Characterization of Antibodies

by Medical Finance
July 5, 2022
0

When therapeutic proteins form aggregates, they can limit clinical effectiveness and possibly provoke a serious immunogenic response. Thermostability screening by...

The applications of respiratory syncytial virus antigens and antibodies in therapeutic and immunological development

The applications of respiratory syncytial virus antigens and antibodies in therapeutic and immunological development

by Medical Finance
July 5, 2022
0

Recently, Pfizer made public a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Subsequently, there has...

What are the benefits of Irish Life Sciences’ new 2.2 mL square well ‘V’ bottom plate?

Fasters Super-Fidelity DNA Polymerase

by Medical Finance
July 5, 2022
0

The polymerase chain reaction (PCR) is a technique for producing significant amounts of specific DNA from a limited number of...

Combating the consistent emergence of new SARS-CoV-2 variants

Combating the consistent emergence of new SARS-CoV-2 variants

by Medical Finance
July 4, 2022
0

The coronavirus disease-19 (COVID-19) is caused by the novel coronavirus (SARS-CoV-2), a positive-sense single-stranded RNA virus that frequently mutates during...

Examining the potential of CXCR4 and CCR5 as therapeutic targets for cancer and HIV therapy

Potential of CXCR4 and CCR5 as targets for cancer and HIV therapy

by Medical Finance
July 4, 2022
0

Human immunodeficiency virus (HIV) infection is a viral infection that causes acquired immunodeficiency syndrome (AIDS) by gradually destroying certain leukocytes....

Combating Parkinson’s disease, the second most common neurodegenerative disease

Combating Parkinson’s disease

by Medical Finance
July 4, 2022
0

ACROBiosystems, a leading producer of recombinant proteins as well as other essential reagents for support in developing target therapies, vaccines and...

Next Post
Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models

Yale researchers identify accelerated genetic aging in breast tissue adjacent to tumors

When teens blow off parents’ pleas to get vaccinated, the consequences can be deadly

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Innate immunity: the first line of defense against SARS-CoV-2. Image Credit: Kateryna Kon/Shutterstock
    Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation
  • Study: Ablation of CD8 + T-cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron. Image Credit: Giovanni Cancemi / Shutterstock.com
    Impact of genetic changes in Omicron variant on an immunodominant T-cell epitope
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply